Hebei Changshan Biochemical Pharmaceutical Co Ltd - ESG Rating & Company Profile powered by AI
The ESG rating covers 17 United Nations Sustainable Development Goals including: 'Clean Water & Sanitation', 'Reduced Inequalities' and 'Life below Water'. The assessment of Hebei Changshan Biochemical Pharmaceutical Co Ltd is assembled by All Street Sevva using advanced Cognitive Robots. This webpage displays a zero-cost E,S&G report for Hebei Changshan Biochemical Pharmaceutical Co Ltd.
Hebei Changshan Biochemical Pharmaceutical Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Hebei Changshan Biochemical Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Hebei Changshan Biochemical Pharmaceutical Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Hebei Changshan Biochemical Pharmaceutical Co Ltd disclose current and historical energy intensity?
Does Hebei Changshan Biochemical Pharmaceutical Co Ltd report the average age of the workforce?
Does Hebei Changshan Biochemical Pharmaceutical Co Ltd reference operational or capital allocation in relation to climate change?
Does Hebei Changshan Biochemical Pharmaceutical Co Ltd disclose its ethnicity pay gap?
Does Hebei Changshan Biochemical Pharmaceutical Co Ltd disclose cybersecurity risks?
Does Hebei Changshan Biochemical Pharmaceutical Co Ltd offer flexible work?
Does Hebei Changshan Biochemical Pharmaceutical Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Hebei Changshan Biochemical Pharmaceutical Co Ltd disclose the number of employees in R&D functions?
Does Hebei Changshan Biochemical Pharmaceutical Co Ltd conduct supply chain audits?
Does Hebei Changshan Biochemical Pharmaceutical Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Hebei Changshan Biochemical Pharmaceutical Co Ltd conduct 360 degree staff reviews?
Does Hebei Changshan Biochemical Pharmaceutical Co Ltd disclose the individual responsible for D&I?
Does Hebei Changshan Biochemical Pharmaceutical Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Hebei Changshan Biochemical Pharmaceutical Co Ltd disclose current and / or historical scope 2 emissions?
Does Hebei Changshan Biochemical Pharmaceutical Co Ltd disclose water use targets?
Does Hebei Changshan Biochemical Pharmaceutical Co Ltd have careers partnerships with academic institutions?
Did Hebei Changshan Biochemical Pharmaceutical Co Ltd have a product recall in the last two years?
Does Hebei Changshan Biochemical Pharmaceutical Co Ltd disclose incidents of discrimination?
Does Hebei Changshan Biochemical Pharmaceutical Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has Hebei Changshan Biochemical Pharmaceutical Co Ltd issued a profit warning in the past 24 months?
Does Hebei Changshan Biochemical Pharmaceutical Co Ltd disclose parental leave metrics?
Does Hebei Changshan Biochemical Pharmaceutical Co Ltd disclose climate scenario or pathway analysis?
Does Hebei Changshan Biochemical Pharmaceutical Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Hebei Changshan Biochemical Pharmaceutical Co Ltd disclose the pay ratio of women to men?
Does Hebei Changshan Biochemical Pharmaceutical Co Ltd support suppliers with sustainability related research and development?
Does Hebei Changshan Biochemical Pharmaceutical Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Hebei Changshan Biochemical Pharmaceutical Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Hebei Changshan Biochemical Pharmaceutical Co Ltd involved in embryonic stem cell research?
Does Hebei Changshan Biochemical Pharmaceutical Co Ltd disclose GHG and Air Emissions intensity?
Does Hebei Changshan Biochemical Pharmaceutical Co Ltd disclose its waste policy?
Does Hebei Changshan Biochemical Pharmaceutical Co Ltd report according to TCFD requirements?
Does Hebei Changshan Biochemical Pharmaceutical Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Hebei Changshan Biochemical Pharmaceutical Co Ltd disclose energy use targets?
Does Hebei Changshan Biochemical Pharmaceutical Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Hebei Changshan Biochemical Pharmaceutical Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Hebei Changshan Biochemical Pharmaceutical Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of crude heparin, heparin raw materials, and heparin preparations for the treatment of cardiovascular and cerebrovascular diseases in China. Its products include crude heparin sodium, heparin sodium raw materials, heparin sodium injections, low molecular weight heparin calcium raw materials and injections, enoxaparin sodium raw materials and injections, nadra Heparin calcium raw materials, nadroparin calcium injections, and dalteparin sodium raw materials and injections. The company was founded in 2000 and is based in Shijiazhuang, China.